Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00611130Phase 2Completed
Vigabatrin for Treatment of Cocaine Dependence
Cocaine Dependence
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Cincinnati

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Richard De La Garza, II, PhD

Baylor College of Medicine

Moderately Similar
4 trials

Shared therapeutic areas:

Cocaine DependenceMethamphetamine AbuseMethamphetamine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Edward Sellers, MD, PhD

Ventana Clinical Research Corporation

Related
1 trials

Shared therapeutic areas:

Methamphetamine AbuseMethamphetamine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)University of Cincinnati
Collaborated on 1 trial
Similarity Score24%

Theresa Winhusen, Ph.D.

University of Cincinnati

Related
6 trials

Shared therapeutic areas:

Cocaine DependenceMethamphetamine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)University of Cincinnati
Similarity Score20%

Alison Oliveto, PhD

University of Arkansas

Related
8 trials

Shared therapeutic areas:

Methamphetamine DependenceCocaine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

Mehmet Sofuoglu, M.D.,Ph.D.

Yale University

Related
8 trials

Shared therapeutic areas:

Cocaine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Perry F Renshaw, MD, PhD, MBA

University of Utah

Related
4 trials

Shared therapeutic areas:

Methamphetamine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Mehmet Sofuoglu, M.D,Ph.D.

Yale University

Related
4 trials

Shared therapeutic areas:

Cocaine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

John Mendelson, MD

California Pacific Medical Center

Related
4 trials

Shared therapeutic areas:

Methamphetamine Dependence
Similarity Score10%

Yihong Yang, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
4 trials

Shared therapeutic areas:

Cocaine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Wei Hao, MD., Ph.D.

Central South University

Related
4 trials

Shared therapeutic areas:

Methamphetamine Dependence
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00603434Phase 1PrincipalInvestigator

Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)

Methamphetamine AbuseMethamphetamine Dependence
Completed
NCT00611130Phase 2PrincipalInvestigator

Vigabatrin for Treatment of Cocaine Dependence

Cocaine Dependence
Completed

All 2 trials loaded